Lymphocyte Distribution of Peripheral Blood Cells From LTS and Progressors
| Lymphocyte Marker . | LTS . | Progressors . | HIVSeronegative Donors . | P Value* . |
|---|---|---|---|---|
| CD19 (%) | 9 ± 4† | 9 ± 6 | 11 ± 5 | .97 |
| CD56/CD16 (%) | 14 ± 7 | 21 ± 16 | 14 ± 7 | .11 |
| CD3 (%) | 81 ± 5 | 71 ± 18 | 71 ± 8 | .03 |
| CD4 (%) | 35 ± 7 | 4 ± 3 | 41 ± 6 | <.01 |
| CD4+cells/μL | 824 ± 208 | 51 ± 49 | 686 ± 217‡ | <.01 |
| CD8 (%) | 46 ± 10 | 63 ± 16 | 28 ± 9 | .03 |
| CD8+cells/μL | 1,122 ± 476 | 812 ± 708 | 443 ± 146 | .14 |
| CD4+:CD8+ cell ratio | 0.81 ± 0.31 | 0.07 ± 0.06 | 1.63 ± 63 | <.01 |
| Lymphocyte Marker . | LTS . | Progressors . | HIVSeronegative Donors . | P Value* . |
|---|---|---|---|---|
| CD19 (%) | 9 ± 4† | 9 ± 6 | 11 ± 5 | .97 |
| CD56/CD16 (%) | 14 ± 7 | 21 ± 16 | 14 ± 7 | .11 |
| CD3 (%) | 81 ± 5 | 71 ± 18 | 71 ± 8 | .03 |
| CD4 (%) | 35 ± 7 | 4 ± 3 | 41 ± 6 | <.01 |
| CD4+cells/μL | 824 ± 208 | 51 ± 49 | 686 ± 217‡ | <.01 |
| CD8 (%) | 46 ± 10 | 63 ± 16 | 28 ± 9 | .03 |
| CD8+cells/μL | 1,122 ± 476 | 812 ± 708 | 443 ± 146 | .14 |
| CD4+:CD8+ cell ratio | 0.81 ± 0.31 | 0.07 ± 0.06 | 1.63 ± 63 | <.01 |
*P values obtained upon comparison of statistical significance between LTS and Progressors using the Mann-Whitney U test. Bold numbers indicate that the value is considered statistically significant.
Mean ± SD.
Value for the normal range of CD4+ cells/μL provided by the Clinical Laboratories of the Medical Center at the University of California, San Francisco using standard protocols is 424 to 1,671 cells/μL.